From: The ACTwatch project: methods to describe anti-malarial markets in seven countries
Category | Indicator description |
---|---|
Availability | Proportion of outlets that: |
 | • Have in stock: any anti-malarial, specified anti-malarial categories |
 | • Reported no disruption in stock of anti-malarials in the last three months |
 | • Have either rapid diagnostic tests or microscopic blood testing facilities |
Price | • Median price of a full adult course by anti-malarial category |
 | • Household price of fever episode treated with an anti-malarial |
Market Share | • Total volume of an anti-malarial category sold or distributed in the last week as a proportion of the total volume of all anti-malarials sold or distributed in the last week |
Provider/wholesaler knowledge and behaviour | Proportion of providers that: |
 | • Correctly state: the recommended first line treatment, the correct dosing regimen |
 | • Can list at least one danger sign in a child that requires referral to a public health facility |
Use | Proportion of children under five with fever in the past 2 weeks that: |
 | • Received anti-malarial treatment, by anti-malarial category, and source, the same or next of fever onset, by socio-economic quintile |
 | • Received a blood test for malaria the same or next day of fever onset |
Caregiver knowledge and behaviour | Proportion of Caregivers that: |
 | • Sought treatment for fever, by source, and reason(s) for this choice(s) |
 | • Can name the first-line drug. Know a common brand of first-line ACT. |
 | • Request a specific anti-malarial by category or brand name from providers. |
 | • Express their opinion on the most effective malaria treatment for adults, by anti-malarial category |
Supply chain structure | • Minimum and maximum number of steps in the distribution chain |
 | • Proportion of wholesalers that engage in specified business practices |
 | • Proportion of wholesalers that have specific categories of anti-malarials and RDTs in stock |
 | • Median percent and absolute mark-up applied by wholesalers, and retailers, by anti-malarial category |